Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Bellinger Andrew Create: Alert

All | News | Filings
Date FiledTypeDescription
12/16/2022 4 Bellinger Andrew (CSO & CMO) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Exercised 36,000 options to buy @ $2.87, valued at $103.3k
12/02/2022 4 Bellinger Andrew (CSO & CMO) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Sold 865 shares @ $22.95, valued at $19.9k
09/27/2022 4 Bellinger Andrew (CSO & CMO) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Sold 6,632 shares @ $34.666, valued at $229.9k
Sold 13,368 shares @ $35.5927, valued at $475.8k
Sold 36,798 shares @ $35.3091, valued at $1.3M
Sold 3,202 shares @ $36.0336, valued at $115.4k
Exercised 40,000 options to buy @ $1.48, valued at $59.2k
Exercised 20,000 options to buy @ $1.48, valued at $29.6k
07/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/15/2022 4 Bellinger Andrew (Chief Scientific Officer) has filed a Form 4 on Verve Therapeutics, Inc.
Txns: Granted 125,000 options to buy @ $30.94, valued at $3.9M
12/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2021 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy